Hillenbrand Inc

Hillenbrand — Q1 2025 Earnings Presentation

20 slides from Hillenbrand's earnings presentation, Feb 6, 2025

  1. Slide 1: First Quarter FY 2025 Earnings Call Presentation

    First Quarter FY 2025 Earnings Call Presentation February 6, 2024

  2. Slide 2: Hillenbrand Call Participants

    Hillenbrand Call Participants Kim Ryan Bob VanHimbergen Sam Mynsberge President & CEO SVP & CFO VP, Investor Relations 2

  3. Slide 3: Disclosure Regarding Forward-Looking Statements

    Disclosure Regarding Forward-Looking Statements Throughout this earnings presentation, we make a number of “forward-looking statements,” including statements that are within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as a

  4. Slide 4: Q1 Overview

    Q1 Overview Q1 2025 Key Metrics1,2 • Continued portfolio transformation with majority sale of Milacron injection molding and extrusion business within MTS for $287 million; -9% $773M $707M after tax net proceeds of ~$250 million to be used for debt paydown Revenue • Transaction enhances margin profi

  5. Slide 5: Q1 Consolidated Performance

    Q1 Consolidated Performance1 Revenue Adj. EBITDA2 Adj. EPS2 Operating Cash Flow -9% -15% -19% +13M $773 $114 $97 $0.69 $707 $0.56 $(11) $(24) Q1 2024 Q1 2025 Q1 2024 Q1 2025 Q1 2024 Q1 2025 Q1 2024 Q1 2025 Performance Highlights1,2 Business Update2 • Revenue decreased 9%, primarily driven by lower v

  6. Slide 6: Segment Performance: Advanced Process Solutions

    Segment Performance: Advanced Process Solutions Revenue Adj. EBITDA1 Adj. EBITDA Margin1 -10% -14% -70 bps $568 $511 16.9% $96 16.2% $83 Q1 2024 Q1 2025 Q1 2024 Q1 2025 Q1 2024 Q1 2025 Performance Highlights1 Business Update • Revenue of $511 million decreased 10%, primarily driven by lower volume p

  7. Slide 7: Segment Performance: Molding Technology Solutions

    Segment Performance: Molding Technology Solutions Revenue Adj. EBITDA1 Adj. EBITDA Margin1 -5% -15% -170 bps $205 $196 $32 $27 15.7% 14.0% Q1 2024 Q1 2025 Q1 2024 Q1 2025 Q1 2024 Q1 2025 Performance Highlights1 Business Update • Revenue of $196 million decreased 5%, driven by lower volume • Demand i

  8. Slide 8: Capital Deployment / Capital Position

    Capital Deployment / Capital Position Maintain Appropriate Leverage Liquidity3 ($M) Debt Maturity Schedule4 ($M) • Desired net leverage1 range of 1.7x – 2.7x • Top priority for cash flow is reducing leverage to return to preferred range Cash $690 • Net proceeds after tax of ~$250M from Milacron tran

  9. Slide 9: Milacron Transaction Summary

    Milacron Transaction Summary ▪ Hillenbrand has entered into a definitive agreement to sell a majority stake in the Milacron injection molding and extrusion business to an affiliate of Bain Capital Transaction ▪ Purchase price of $287M for ~51% of the company, subject to customary closing adjustments

  10. Slide 10: Reconciliation of Previous Guidance

    Reconciliation of Previous Guidance Free Cash $ millions, except EPS Revenue Adj. EBITDA2 Adj. EPS2 Flow Previous Guidance $2,925 – $3,090 $452 – $488 $2.80 – $3.15 ~$150 Impact of Milacron Sale1 ~$300 ~$41 ~$0.35 ~$45 Previous Guidance – Adjusted for $2,625 - $2,790 $411 - $447 $2.45 - $2.80 ~$105

  11. Slide 11: FY25 Updated Guidance – Maintaining Core Outlook

    FY25 Updated Guidance – Maintaining Core Outlook Advanced Molding FY25 Key Assumptions (at midpoint) Hillenbrand Process Technology Solutions Solutions APS • Orders consistent with FY24 overall, improving in 2H vs. 1H Revenue $2,625 - $2,790 $2,050 - $2,175 $575 - $615 • Modest growth in aftermarket

  12. Slide 12: Q&A

    Q&A HILLENBRAND 12

  13. Slide 13: Replay Information

    Replay Information • Dial-in for US and Canada: +1 (877) 407-8012 • Dial-in for International: +1 (412) 902-1013 • Conference ID: 13751135 • Date/Time: Available until midnight ET, Thursday, February 20, 2025 • Log-on to: http://ir.hillenbrand.com 13

  14. Slide 14: Appendix

    Appendix HILLENBRAND

  15. Slide 15: Disclosure Regarding Non-GAAP Financial Measures

    Disclosure Regarding Non-GAAP Financial Measures In addition to the financial measures prepared in accordance with United States generally accepted accounting principles (GAAP), this earnings presentation also contains non-GAAP operating performance measures. These non-GAAP financial measures are re

  16. Slide 16: Reconciliation of Adjusted EBITDA to Consolidated Net Income

    Reconciliation of Adjusted EBITDA to Consolidated Net Income Three Months Ended December 31, (in millions) 2024 2023 Adjusted EBITDA: Advanced Process Solutions $ 82.8 $ 96.0 Molding Technology Solutions 27.4 32.1 Corporate (13.1) (14.0) Add: Loss from discontinued operations (net of income tax expe

  17. Slide 17: Reconciliation of Income to Adjusted Net Income & Diluted EPS to Adjusted

    Reconciliation of Income to Adjusted Net Income & Diluted EPS to Adjusted Diluted EPS for Continuing Operations Three Months Ended December 31, (in millions, except per share data) 2024 2023 Income from continuing operations $ 8.9 $ 19.5 Less: Net income attributable to noncontrolling interests 2.5

  18. Slide 18: Reconciliation of Consolidated Net Income to Adjusted EBITDA

    Reconciliation of Consolidated Net Income to Adjusted EBITDA Three Months Ended December 31, (in millions) 2024 2023 Consolidated net income $ 8.9 $ 19.2 Interest expense, net 25.1 29.8 Income tax expense 6.4 10.0 Depreciation and amortization 37.9 38.8 EBITDA 78.3 97.8 Loss from discontinued operat

  19. Slide 19: Ratio of Net Debt to Adjusted EBITDA for the trailing twelve months

    Ratio of Net Debt to Adjusted EBITDA for the trailing twelve months ended December 31, (in millions) 2024 Current portion of long-term debt $ 20.9 Long-term debt 1,885.0 Total debt 1,905.9 Less: Cash and cash equivalents 208.0 Net debt $ 1,697.9 Adjusted EBITDA for the trailing twelve months ended $

  20. Slide 20: Reconciliation of Net Cash Flows

    Reconciliation of Net Cash Flows Three Months Ended December 31, (in millions) 2024 2023 Cash flows (used in) provided by: Operating activities from continuing operations $ (11.3) $ (24.0) Investing activities from continuing operations 9.5 (15.1) Financing activities from continuing operations 26.8

Hillenbrand — Q1 2025 Earnings Presentation on 6ix